Homoeopathic Drug Pathogenetic Trials is a unique concept of testing the action of Drug Substance on Healthy individual for the treatment of sick in Homoeopathic system of medicine and Central Council for Research in Homoeopathy over the years have devised the proving Protocol which is highly acclaimed by the international community of Homoeopaths observed Dr.Anil Khurana Deputy Director General Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt .of India, while inaugurating the workshop on Homoeopathic Drug Pathogenetic Trials at JIMS Homoeopathic Medical College & Hospital, Hyderabad held on 6th May 2017. Dr.Arvind Kothe Director JIMS Homoeopathic Medical College & Hospital Presided over the function.
While appreciating the excellent infrastructure and the environment for higher learning at JIMS Homoeopathic Medical College & Hospital, Dr.Anil Khurana has assured to provide Necessary technical support to the institution to promote Research.
Dr. Anil Khurana in his address highlighted on the Problems encountered in Hahnemann proving, history of Evolution of drug proving to Double blind with inclusion of Lab investigations, development of CCRH Protocol – institutional protocol published in British Homoeopathic Journal, Major changes from 1987 to new protocol 2010 – age, doses, scale, washout period, potency quota, compared studies of both the old and new protocols, the placebo symptoms and proving symptoms produced from various quota potencies,etc
Dr. Pritha Mehra Research officer (H) Central Council for Research in Homoeopathy,during her address presented the latest protocol with changes in inclusion and exclusion criteria,process of drug proving,safety assessment – serious adverse events, adverse event, adverse drug reactions, its management and reporting,date collection, processing, analysis (unblinding) and management.
Dr.K.Kalpavalli the in charge of the Drug Proving Unit presented the activities related to Drug Pathogenetic trials at JIMS Homoeopathic Medical College & Hospital.
